4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000423
Director sold 10,300 shares at $13.50 ($139,050)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. Director | 2018-05-14 | Sale | −10,300 | $13.50 | $139,050 | 5,091,010 | I: show line 1 in the form |
| Open-market sales · 10,300 sh · avg $13.50 · $139,050 | |||||||
Loading xslF345X03/ss92648_4.xml…